Joud Hajjar

Joud Hajjar

Baylor College of Medicine - Houston / United States
Medical and Health Sciences / Immunology
AD Scientific Index ID: 846522
person_outline Joud Hajjar's MOST POPULAR ARTICLES
1-) Targeting the indoleamine 2, 3-dioxygenase pathway in cancerYW Moon, J Hajjar, P Hwu, A NaingJournal for immunotherapy of cancer 3 (1), 1-10, 20153022015
2-) Incidence of immune-related adverse events and its association with treatment outcomes: the MD Anderson Cancer Center experienceT Fujii, RR Colen, MA Bilen, KR Hess, J Hajjar, ME Suarez-Almazor, ...Investigational new drugs 36 (4), 638-646, 20181322018
3-) Phase 2 study of pembrolizumab in patients with advanced rare cancersA Naing, F Meric-Bernstam, B Stephen, DD Karp, J Hajjar, JR Ahnert, ...Journal for immunotherapy of cancer 8 (1), 20201012020
4-) Radiomics to predict immunotherapy-induced pneumonitis: proof of conceptRR Colen, T Fujii, MA Bilen, A Kotrotsou, S Abrol, KR Hess, J Hajjar, ...Investigational new drugs 36, 601-607, 20181132018
5-) T-cell agonists in cancer immunotherapyY Choi, Y Shi, CL Haymaker, A Naing, G Ciliberto, J HajjarJournal for immunotherapy of cancer 8 (2), 20201052020